Drugs / BMI2004
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05922813 | Jun 2022 → Mar 2023 | — | BMI Korea | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMI2004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05922813 ↗ |
| Route | Other | “single-dose intradermal injection of BMI2004 Inj.” NCT05922813 ↗ |